Yoshiharu Kikawa

1.4k total citations
51 papers, 1.1k citations indexed

About

Yoshiharu Kikawa is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Yoshiharu Kikawa has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Clinical Biochemistry and 10 papers in Physiology. Recurrent topics in Yoshiharu Kikawa's work include Metabolism and Genetic Disorders (18 papers), Mitochondrial Function and Pathology (12 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Yoshiharu Kikawa is often cited by papers focused on Metabolism and Genetic Disorders (18 papers), Mitochondrial Function and Pathology (12 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Yoshiharu Kikawa collaborates with scholars based in Japan, United States and Netherlands. Yoshiharu Kikawa's co-authors include Shuh Narumiya, Akio Nakai, M. Sudo, Yosuke Shigematsu, M Fukushima, O Hayaishi, Masataka Yokode, Tomoko Kita, Toshiya Ogorochi and C Kawai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Yoshiharu Kikawa

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiharu Kikawa Japan 15 555 235 226 182 176 51 1.1k
Tomas Welbourne United States 19 592 1.1× 224 1.0× 339 1.5× 56 0.3× 175 1.0× 49 1.4k
Hisazumi Araki Japan 18 422 0.8× 193 0.8× 102 0.5× 96 0.5× 87 0.5× 27 1.2k
Bardia Askari United States 15 802 1.4× 175 0.7× 56 0.2× 65 0.4× 134 0.8× 20 1.3k
Yael Riahi Israel 19 473 0.9× 287 1.2× 109 0.5× 122 0.7× 63 0.4× 23 1.2k
Jun Hao China 23 629 1.1× 167 0.7× 96 0.4× 79 0.4× 176 1.0× 57 1.3k
Miriam H. Fukami Norway 18 399 0.7× 201 0.9× 147 0.7× 58 0.3× 48 0.3× 31 919
Farah Kramer United States 20 606 1.1× 157 0.7× 115 0.5× 54 0.3× 195 1.1× 32 1.4k
Chiara Gatti Italy 8 407 0.7× 351 1.5× 81 0.4× 60 0.3× 45 0.3× 13 999
Qingjuan Liu China 23 523 0.9× 92 0.4× 118 0.5× 61 0.3× 149 0.8× 52 1.1k
Alois Sellmayer Germany 20 380 0.7× 168 0.7× 29 0.1× 99 0.5× 95 0.5× 34 1.1k

Countries citing papers authored by Yoshiharu Kikawa

Since Specialization
Citations

This map shows the geographic impact of Yoshiharu Kikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiharu Kikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiharu Kikawa more than expected).

Fields of papers citing papers by Yoshiharu Kikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiharu Kikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiharu Kikawa. The network helps show where Yoshiharu Kikawa may publish in the future.

Co-authorship network of co-authors of Yoshiharu Kikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiharu Kikawa. A scholar is included among the top collaborators of Yoshiharu Kikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiharu Kikawa. Yoshiharu Kikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasegawa, Yukihiro, et al.. (2003). Intravenous glycerol therapy should not be used in patients with unrecognized fructose‐1,6‐bisphosphatase deficiency. Pediatrics International. 45(1). 5–9. 10 indexed citations
2.
Tanizawa, Akihiko, et al.. (1999). Serum Soluble CD44 in Pediatric Patients With Acute Leukemia. Journal of Pediatric Hematology/Oncology. 21(5). 384–388. 11 indexed citations
3.
Kikawa, Yoshiharu, Manabu Inuzuka, Junichi Koga, et al.. (1997). Identification of Genetic Mutations in Japanese Patients with Fructose-1, 6-Bisphosphatase Deficiency. The American Journal of Human Genetics. 61(4). 852–861. 49 indexed citations
5.
Kikawa, Yoshiharu, Manabu Inuzuka, Seiji Kaji, et al.. (1995). Identification of a Genetic Mutation in a Family with Fructose-1,6-bisphosphatase Deficiency. Biochemical and Biophysical Research Communications. 210(3). 797–804. 21 indexed citations
6.
Nakai, Akio, et al.. (1995). MRI findings of Zellweger syndrome. Pediatric Neurology. 13(4). 346–348. 14 indexed citations
7.
Nakai, Akira, Yosuke Shigematsu, Yoshiharu Kikawa, et al.. (1994). Diffuse leukodystrophy with a large-scale mitochondrial DNA deletion. The Lancet. 343(8910). 1397–1398. 18 indexed citations
9.
Nakai, Akira, et al.. (1993). Urinary sugar phosphates and related organic acids in fructose‐1,6‐diphosphatase deficiency. Journal of Inherited Metabolic Disease. 16(2). 408–414. 13 indexed citations
10.
Kikawa, Yoshiharu, Takeshi Miyanomae, Yoshito Inoue, et al.. (1992). Urinary leukotriene E4 after exercise challenge in children with asthma. Journal of Allergy and Clinical Immunology. 89(6). 1111–1119. 107 indexed citations
11.
Nakai, Akio, et al.. (1991). Pathophysiologic Study on Methylmalonic Aciduria: Decrease in Liver High-Energy Phosphate after Propionate Loading in Rats. Pediatric Research. 30(1). 5–10. 6 indexed citations
12.
Kikawa, Yoshiharu, et al.. (1990). Leukotriene B4 production in children with steroid-responsive nephrotic syndrome. Pediatric Nephrology. 4(4). 343–344.
13.
Shigematsu, Yosuke, et al.. (1990). Delayed auditory brainstem response in thiamin-deficient rats.. Journal of Nutritional Science and Vitaminology. 36(3). 209–215. 7 indexed citations
14.
Matsuda, Masahiro, et al.. (1990). Diagnosis of Iliopsoas Pyomyositis by Ultrasonography and CT. Pediatrics International. 32(5). 555–558. 1 indexed citations
15.
Shigematsu, Yosuke, Ichiro Mori, Akira Nakai, et al.. (1990). Acute infantile hemiplegia in a patient with propionic acidaemia. European Journal of Pediatrics. 149(9). 659–660. 9 indexed citations
16.
Shigematsu, Yosuke, Yoshiharu Kikawa, Masakatsu Sudo, & Yoshinori Itokawa. (1989). Branched-chain .ALPHA.-ketoacids and related acids in thiamin-deprived rats.. Journal of Nutritional Science and Vitaminology. 35(3). 163–170. 1 indexed citations
17.
Hirata, Yukihiro, Hideki Hayashi, Shosuke Ito, et al.. (1988). Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine.. Journal of Biological Chemistry. 263(32). 16619–16625. 138 indexed citations
18.
Yokode, Masataka, Tomoko Kita, Yoshiharu Kikawa, et al.. (1988). Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein.. Journal of Clinical Investigation. 81(3). 720–729. 143 indexed citations
19.
Kikawa, Yoshiharu, et al.. (1987). Assay of leukotriene B4 production in stimulated whole blood. Ensho. 8(5). 449–453. 1 indexed citations
20.
Kikawa, Yoshiharu, Shuh Narumiya, & Moriyuki Fukushima. (1984). 9-Deoxy-Δ9,Δ12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. 20(1). 1317–1321. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026